285 related articles for article (PubMed ID: 16640745)
1. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA
Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
[No Abstract] [Full Text] [Related]
4. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy.
Lui NL; Thumboo J; Fong KY
Int J Rheum Dis; 2009 Dec; 12(4):366-9. PubMed ID: 20374378
[TBL] [Abstract][Full Text] [Related]
5. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy for childhood-onset systemic lupus erythematosus.
Willems M; Haddad E; Niaudet P; Koné-Paut I; Bensman A; Cochat P; Deschênes G; Fakhouri F; Leblanc T; Llanas B; Loirat C; Pillet P; Ranchin B; Salomon R; Ulinski T; Bader-Meunier B;
J Pediatr; 2006 May; 148(5):623-627. PubMed ID: 16737873
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.
Abdwani R; Mani R
Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
Perrotta S; Locatelli F; La Manna A; Cennamo L; De Stefano P; Nobili B
Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
[TBL] [Abstract][Full Text] [Related]
9. [Rituximab in systemic lupus erythematosus. Part I. Theoretical basis].
Kardynał A; Rudnicka L
Pol Merkur Lekarski; 2010 Aug; 29(170):131-4. PubMed ID: 20842829
[TBL] [Abstract][Full Text] [Related]
10. Rituximab to treat active SLE in a hemodialysis patient.
Nadri QJ
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1085-6. PubMed ID: 19861879
[No Abstract] [Full Text] [Related]
11. [Rituximab in systemic lupus erythematosus. Part II: review of clinical experience].
Kardynał A; Rudnicka L
Pol Merkur Lekarski; 2010 Aug; 29(170):135-40. PubMed ID: 20842830
[TBL] [Abstract][Full Text] [Related]
12. Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report.
Hennigan S; Channick RN; Silverman GJ
Lupus; 2008 Aug; 17(8):754-6. PubMed ID: 18625655
[TBL] [Abstract][Full Text] [Related]
13. B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus.
Podolskaya A; Stadermann M; Pilkington C; Marks SD; Tullus K
Arch Dis Child; 2008 May; 93(5):401-6. PubMed ID: 18039744
[TBL] [Abstract][Full Text] [Related]
14. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R
Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
[TBL] [Abstract][Full Text] [Related]
15. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.
Pottier V; Pierrot M; Subra JF; Mercat A; Kouatchet A; Parrot A; Augusto JF
Lupus; 2011 May; 20(6):656-9. PubMed ID: 21335399
[TBL] [Abstract][Full Text] [Related]
16. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
Smith KG; Jones RB; Burns SM; Jayne DR
Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
Kotani T; Takeuchi T; Kawasaki Y; Hirano S; Tabushi Y; Kagitani M; Makino S; Hanafusa T
Lupus; 2006; 15(10):683-5. PubMed ID: 17120596
[TBL] [Abstract][Full Text] [Related]
19. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
Kittaka K; Dobashi H; Baba N; Iseki K; Kameda T; Susaki K; Kitanaka A; Kubota Y; Ishida T
Scand J Rheumatol; 2008; 37(5):390-3. PubMed ID: 18609263
[TBL] [Abstract][Full Text] [Related]
20. Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report.
Nellessen CM; Pöge U; Brensing KA; Sauerbruch T; Klehr HU; Rabe C
Nephrol Dial Transplant; 2008 Jan; 23(1):385-6. PubMed ID: 17933839
[No Abstract] [Full Text] [Related]
[Next] [New Search]